This inhibitory ligand binds to its receptor, PD-1, suppressing T cell activation and promoting tumor escape and progression, while expression of Fas ligand (FasL) on PMN-MDSCs has been shown in pre-clinical studies to promote the apoptosis of TILs [100]. This evidence concerns the gene PDCD1 and neoplasm.